
(HealthDay News) – Pfizer Inc. announced Saturday that it has two possible candidates that beat back Omicron infection more effectively than its original vaccine. The news follows Moderna’s announcement last week that its Omicron booster shot showed greater protection against the highly contagious variant. On Tuesday, the U.S. Food and Drug Administration’s scientific advisers will… read on > read on >